Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Day-time response variation of dexamphetamine versus lisdexamfetamine in adults with ADHD
NL-OMON50997Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dextroamphetamine and lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Amsterdam University Medical Center. Primary endpoint: Comparison of the PK/PD profile. Started Jul 2021; status: recruiting.
02
Drugs
dextroamphetaminelisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON50997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50997.